Company Logo

Home industry healthcare merck to buy rare disease drug makers Acceleron for $11.5 billion

Merck to buy rare disease drug makers Acceleron for $11.5 billion


Merck to buy rare disease drug makers Acceleron for $11.5 billion

Merck & Co. to acquire rare disease drug makers Acceleron for $11.5 billion in a bid to expand its drug portfolio.

U.S pharmaceutical giants Merck & Co. will buy drugmaker Acceleron Pharma for $11.5 billion as Merck & Co. looks to expand the drugs for rare diseases in its portfolio.The boards of both pharmaceutical companies have agreed to an all-cash deal with Merck paying $180 per share, a premium of 2.6% to the stock’s last closing price.

Massachusetts-based Acceleron focuses primarily on therapeutic drugs that treat cardiovascular and blood-related diseases. The acquisition gives Merck access to a potentially lucrative rare disease drug candidate named Sotatercept. The Sotatercept drug aims to treat Pulmonary Arterial Hypertension (PAH), a rare cardiovascular disease caused by high blood pressure that affects the lungs.

The manufacture of drugs used to treat rare diseases is a lucrative market, as drugmakers charge exorbitant amounts for drugs made to serve small patient populations. Apart from Sotatercept, Merck also will gain access to another drug named Reblozyl, which treats two rare blood-related diseases, including anemia in patients suffering from beta-thalassemia.

The transaction of the sale is expected to be completed in the last quarter of this year

Business News

Recommended News

Most Featured Companies

ciobulletin-aatrix software.jpg ciobulletin-abbey research.jpg ciobulletin-anchin.jpg ciobulletin-croow.jpg ciobulletin-keystone employment group.jpg ciobulletin-opticwise.jpg ciobulletin-outstaffer.jpg ciobulletin-spotzer digital.jpg ciobulletin-virgin incentives.jpg ciobulletin-wool & water.jpg ciobulletin-archergrey.jpg ciobulletin-canon business process services.jpg ciobulletin-cellwine.jpg ciobulletin-digital commerce bank.jpg ciobulletin-epic golf club.jpg ciobulletin-frannexus.jpg ciobulletin-growth institute.jpg ciobulletin-implantica.jpg ciobulletin-kraftpal technologies.jpg ciobulletin-national retail solutions.jpg ciobulletin-pura.jpg ciobulletin-segra.jpg ciobulletin-the keith corporation.jpg ciobulletin-vivolor therapeutics inc.jpg ciobulletin-cox.jpg ciobulletin-lanner.jpg ciobulletin-neuro42.jpg ciobulletin-Susan Semmelmann Interiors.jpg ciobulletin-alpine distilling.jpg ciobulletin-association of black tax professionals.jpg ciobulletin-c2ro.jpg ciobulletin-envirotech vehicles inc.jpg ciobulletin-leafhouse financial.jpg ciobulletin-stormforge.jpg ciobulletin-tedco.jpg ciobulletin-transigma.jpg ciobulletin-retrain ai.jpg
ciobulletin-abacus semiconductor corporation.jpg ciobulletin-agape treatment center.jpg ciobulletin-cloud4wi.jpg ciobulletin-exponential ai.jpg ciobulletin-lexrock ai.jpg ciobulletin-otava.jpg ciobulletin-resecurity.jpg ciobulletin-suisse bank.jpg ciobulletin-wise digital partners.jpg ciobulletin-appranix.jpg ciobulletin-autoreimbursement.jpg ciobulletin-castle connolly.jpg ciobulletin-cgs.jpg ciobulletin-dth expeditors.jpg ciobulletin-form.jpg ciobulletin-geniova.jpg ciobulletin-hot spring it.jpg ciobulletin-kirkman.jpg ciobulletin-matrix applications.jpg ciobulletin-power hero.jpg ciobulletin-rittenhouse.jpg ciobulletin-stt logistics group.jpg ciobulletin-upstream works.jpg ciobulletin-x2engine.jpg ciobulletin-kastle.jpg ciobulletin-logix.jpg ciobulletin-preclinical safety (PCS) consultants ltd.jpg ciobulletin-xcastlabs.jpg ciobulletin-american battery solutions inc.jpg ciobulletin-book4time.jpg ciobulletin-d&l education solutions.jpg ciobulletin-good good natural sweeteners llc.jpg ciobulletin-sigmetrix.jpg ciobulletin-syncari.jpg ciobulletin-tier44 technologies.jpg ciobulletin-xaana.jpg

Latest Magazines

© 2024 CIO Bulletin Inc. All rights reserved.